CION Ameerpet
A clear, caring overview of childhood lymphoma for parents. Learn what paediatric lymphoma is, the early signs to watch for, how it is diagnosed, and how CION's team coordinates treatment as a bridge to dedicated paediatric cancer care.
Childhood lymphoma is a cancer of the lymphatic system — the network of lymph nodes, vessels and immune organs (such as the spleen and thymus) that helps a child fight infection. It begins when lymphocytes, a type of white blood cell, start to grow in an abnormal, uncontrolled way. Lymphoma is one of the more common cancers of childhood and adolescence, and the same word covers a wide range of subtypes with different behaviour.
The most important thing for a parent to understand is that lymphoma in children is among the most treatable of childhood cancers. Modern, carefully designed paediatric protocols achieve high cure rates, and treatment is planned not only to remove the cancer but to protect a child's long-term growth, heart, lungs and fertility. Paediatric lymphoma falls into two broad families — Hodgkin lymphoma and non-Hodgkin lymphoma — which we explain further down this page.
This overview walks through the signs, how the diagnosis is made, the subtypes seen in children, and how treatment works. For the wider picture, see our lymphoma hub, and for dedicated children's cancer pathways see the paediatric cancer hub. CION coordinates paediatric lymphoma care as a bridge into these dedicated children's services.
Lymphoma is one of the three most common cancers of childhood and adolescence, and it is also one of the most curable. Thanks to decades of collaborative paediatric clinical trials, long-term survival for children with Hodgkin lymphoma now sits in the region of ~90% in published series, and many high-grade paediatric non-Hodgkin lymphomas also achieve high cure rates with modern intensive protocols. (Source: published paediatric oncology outcome series, consistent with NCCN and ESMO guidance; figures vary by subtype, stage and individual.)
Most swollen glands in children are caused by ordinary infections — not cancer. But some patterns are worth checking promptly, especially when they persist or come with other symptoms.
Swelling that is persistent, painless or growing — especially alongside fever, weight loss or night sweats — should be reviewed by a doctor without delay. Speak to a CION specialist if these signs continue in your child.
Childhood lymphoma is highly treatable when it is diagnosed accurately and managed by an experienced, coordinated team.
Getting the exact lymphoma subtype right — through expert biopsy review and molecular testing — is what lets treatment be matched precisely to your child. CION coordinates biopsy, bone-marrow examination and molecular testing directly.
Every case is discussed by a multidisciplinary tumour board — haematology, medical and radiation oncology together — before the plan is finalised, in line with NCCN and ESMO principles.
Chemotherapy, immunotherapy, targeted therapy and radiation are delivered in-house. Where a stem-cell transplant is needed, it is coordinated through an accredited partner transplant facility.
Because most children are cured, care continues long after treatment — with structured survivorship follow-up to protect growth, heart, lungs and fertility, and a smooth bridge into paediatric cancer follow-up.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just received your child's lymphoma diagnosis, want to understand the subtype and stage, or need a second opinion before treatment begins? CION's team is here to help.
All lymphomas are divided into two broad families, and both occur in children — though they behave differently and are treated differently. Getting the family and exact subtype right, on biopsy, is the foundation of the whole plan.
Hodgkin lymphoma is defined by a particular abnormal cell (the Reed-Sternberg cell) seen on biopsy. In children and teenagers it most often appears as painless swollen nodes in the neck or chest, and it tends to spread in a fairly predictable, orderly way from one node group to the next. It is highly curable. Read more on our dedicated Hodgkin lymphoma in children & teens page.
Non-Hodgkin lymphoma (NHL) is a larger group. In children, the subtypes seen are usually fast-growing (high-grade) and need prompt treatment — but they also respond very well to intensive chemotherapy. The main paediatric NHL subtypes include Burkitt lymphoma and lymphoblastic lymphoma. See our non-Hodgkin lymphoma in children page for detail.
Diagnosing lymphoma in a child — and pinning down the exact subtype and stage — takes a step-by-step pathway. CION delivers the biopsy coordination, bone-marrow examination, molecular testing and imaging review directly, with every case reviewed at a tumour board.
A biopsy — removing a lymph node or a tissue sample — is the only way to confirm lymphoma and identify its exact subtype. A pathologist examines the tissue under the microscope and with molecular markers (such as CD20, CD30 and MYC) to distinguish Hodgkin from non-Hodgkin lymphoma and to name the precise subtype, which guides everything that follows.
Once lymphoma is confirmed, imaging — including PET-CT and CT or MRI — is used to see how far it has spread, which defines the stage. A bone-marrow examination may also be done to check whether the marrow is involved. Accurate staging tells the team how intensive treatment needs to be.
Molecular markers refine the diagnosis and, in some subtypes, guide the choice of therapy — for example, an anti-CD20 antibody may be added when the lymphoma cells carry the CD20 marker. This testing is arranged as standard on your child's biopsy tissue. Staging and subtyping follow NCCN and ESMO principles.
In children, non-Hodgkin lymphomas are almost always fast-growing (high-grade) subtypes — the very opposite of the slow-growing, indolent forms that are common in older adults. This sounds alarming, but it is why paediatric NHL responds so dramatically to intensive combination chemotherapy given over a defined period, with high cure rates. It is also why prompt, accurate diagnosis matters so much. (Source: paediatric oncology literature, consistent with NCCN and ESMO guidance.)
The plan depends on the family (Hodgkin or non-Hodgkin), the exact subtype, the stage and your child's overall health. Every case is reviewed by CION's multidisciplinary tumour board before treatment begins. The main building blocks are:
Most childhood lymphomas are treated primarily with combination chemotherapy given in cycles, because these cancers are usually very responsive. CION's team delivers systemic therapy directly. The specific regimen is matched to the subtype — see our lymphoma treatment in Hyderabad page for how regimens are chosen (we describe therapy here by class, not by brand name).
For lymphomas whose cells carry certain markers, an anti-CD20 monoclonal antibody or other targeted agents may be added to chemotherapy to improve results. These are delivered in-house alongside supportive care.
In some children, radiation therapy is used for specific sites of disease. CION delivers precision radiation such as IMRT, shaped carefully to spare a child's growing, healthy tissue — used judiciously and only when the benefit is clear.
For relapsed or high-risk lymphoma, a stem-cell transplant may be recommended. This is coordinated through an accredited partner transplant facility rather than performed in-house; CION manages the surrounding chemotherapy, monitoring and supportive care and stays involved throughout the referral.
Childhood lymphoma is one of the more curable childhood cancers. In published series, Hodgkin lymphoma in children and teens carries a long-term survival in the region of ~90%, and many paediatric non-Hodgkin lymphomas also achieve high cure rates with modern intensive protocols. These figures are drawn from published paediatric oncology series and are consistent with NCCN and ESMO-aligned guidance — but they vary by individual, by subtype, by stage at diagnosis and by how the lymphoma responds to treatment, so your child's specialist can give a more personalised estimate.
Because most children are cured, paediatric care puts strong emphasis on long-term survivorship: monitoring for any return of the lymphoma, and watching for possible late effects of treatment on the heart, lungs, thyroid, growth and fertility. CION provides survivorship monitoring directly and bridges each family into dedicated paediatric cancer follow-up pathways.
This overview is the pillar of our childhood lymphoma cluster. Explore each subtype and the wider hubs in depth:
A childhood lymphoma diagnosis carries a lot of nuance, and a second opinion is especially valuable when:
CION offers a dedicated, free written second-opinion service for families. You deserve a plan built around your child's healing, with transparent costs explained up front. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if the subtype is uncertain or staging is incomplete.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Childhood lymphoma is a cancer that begins in the lymphatic system — the network of lymph nodes, vessels and organs (such as the spleen and thymus) that forms part of a child's immune system. It develops when lymphocytes, a type of white blood cell, grow in an abnormal, uncontrolled way. Lymphoma is one of the more common cancers in children and teenagers, and it falls into two broad families: Hodgkin lymphoma in children and non-Hodgkin lymphoma in children. The reassuring part is that paediatric lymphoma is among the most treatable childhood cancers, with many children going on to be long-term survivors. For the full adult and general picture, see our lymphoma hub.
Although the disease families overlap, lymphoma in children behaves and is managed differently from lymphoma in adults. The subtypes seen in children are different — paediatric non-Hodgkin lymphomas are usually fast-growing (high-grade) types such as Burkitt lymphoma and lymphoblastic lymphoma, rather than the slow-growing forms common in older adults. Children generally tolerate intensive treatment better and tend to respond very well, so paediatric protocols are built to maximise cure while carefully protecting long-term growth, fertility and organ function. Because of this, childhood lymphoma is best managed by a team experienced in paediatric cancer. CION coordinates paediatric lymphoma care as a bridge to dedicated paediatric cancer pathways.
The most common first sign is one or more painless, swollen lymph nodes — often in the neck, above the collarbone, in the armpit or groin — that persist for more than two to three weeks and do not settle after an infection. Other signs can include a lasting cough or breathlessness (if nodes in the chest enlarge), a swollen abdomen or early fullness when eating, unexplained fevers, drenching night sweats, unexplained weight loss, persistent tiredness and, sometimes, itching. Most swollen glands in children are due to ordinary infections, not cancer. But swelling that is persistent, painless, or growing — especially with fever, weight loss or night sweats — should be reviewed promptly. Speak to a CION specialist if these signs continue.
Diagnosis begins with a careful examination and blood tests, but the definitive step is a biopsy — removing a lymph node or a small tissue sample so a pathologist can confirm the type of lymphoma. Under a microscope and with molecular testing, the team identifies whether it is Hodgkin or non-Hodgkin lymphoma and the exact subtype, which guides the whole plan. Imaging — including PET-CT and CT/MRI — is used to see how far the lymphoma has spread (its stage), and a bone-marrow examination may be done. CION delivers biopsy coordination, bone-marrow examination, molecular testing and imaging review directly, with every case discussed at a multidisciplinary tumour board. Accurate staging and subtyping, guided by NCCN and ESMO principles, is what allows treatment to be matched precisely to each child.
Most childhood lymphomas are treated primarily with chemotherapy — often a combination given in cycles — because these cancers are usually very responsive to it. Depending on the subtype and stage, treatment may also include immunotherapy such as an anti-CD20 monoclonal antibody, targeted therapy, and in selected cases radiation therapy (delivered with precision techniques such as IMRT to protect growing tissue). CION delivers chemotherapy, immunotherapy, targeted therapy, radiation, and supportive and survivorship care directly. Where a stem-cell transplant is needed for relapsed or high-risk disease, it is coordinated through an accredited partner transplant facility, not performed in-house. Specific drug regimens are matched to the subtype — see our lymphoma treatment in Hyderabad page for how regimens are chosen.
Childhood lymphoma is one of the more curable childhood cancers, and outcomes have improved greatly over recent decades. In published series, Hodgkin lymphoma in children and teens carries a long-term survival in the region of ~90%, and many paediatric non-Hodgkin lymphomas — including Burkitt and lymphoblastic types — also achieve high cure rates with modern intensive protocols. These figures vary by individual, by subtype, by stage at diagnosis and by response to treatment, so your child's specialist can give a more personalised estimate. Alongside cure, paediatric teams focus on long-term survivorship — protecting growth, heart, lung and fertility, and monitoring for late effects for years afterwards. (Outlook figures are drawn from published paediatric oncology series and NCCN/ESMO-aligned guidance; individual results differ.)
Because most children are cured, care does not end when treatment stops — long-term survivorship follow-up is a core part of paediatric lymphoma care. After treatment, children are monitored for any sign of the lymphoma returning and, importantly, for possible late effects of treatment on the heart, lungs, thyroid, bones, growth and fertility, and for the small long-term risk of second cancers. A structured survivorship plan sets out which check-ups and tests are needed and when. CION provides survivorship monitoring directly and coordinates transition into dedicated paediatric cancer follow-up pathways. Families are supported throughout with clear guidance on nutrition, schooling, vaccination timing and emotional wellbeing.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.